COVID-19 Update: Masks Now Optional

Innovation & Research

Creating Tomorrow’s Therapies Today

Minnesota Urology physicians conduct a variety of clinical studies to bring the safest and most effective new urologic products and therapies to men and women suffering from urologic conditions.   

Research That Makes a Difference

At Minnesota Urology, we conduct a variety of clinical studies, from observational studies to large, randomized, controlled interventional clinical trials. We conduct Phase II and Phase III clinical trials that are especially important for getting new treatment options approved for clinical care. Our goal is to make a difference in the lives of our patients, both today and tomorrow.

STUDIES CURRENTLY OPEN FOR
ENROLLMENT OF ELIGIBLE PATIENTS

For more information or to determine if you may be eligible, call Clinical Research at 651-999-7032.

Overactive Bladder/Urinary Urgency Incontinence; Fecal Incontinence; or Non-obstructive Urinary Retention – Females and Males

Evaluation of InterStim Micro System Performance and Safety (ELITE) to confirm Long-term Outcomes

  • A prospective, multi-center post-market study to confirm long-term clinical performance and safety of Medtronic’s implantable InterStim Micro System in males and females who are eligible and elect to have sacral neuromodulation therapy provided by this FDA-approved device (approved for clinical use in 2020). All eligible subjects have the InterStim Micro System implanted and are given active therapy per clinical standard of care.

Urinary Urgency Incontinence – Males and Females

Clinical Study of Neuspera’s Implantable Sacral Nerve Stimulation (SNS) System in Patients with Symptoms of Overactive Bladder

  • A prospective, multi-center, single-arm clinical trial to assess the safety and efficacy of sacral nerve modulation therapy provided by Neuspera’s implantable SNS device for the treatment of overactive bladder and urinary urgency incontinence.

Urinary Urgency Incontinence – Females

BlueWind RENOVA iStim™ for the Treatment of Overactive Bladder

  • A multi-center, prospective, interventional, single arm study to demonstrate the safety and efficacy of tibial neuromodulation therapy provided by the BlueWind RENOVA iStim™ in females for the treatment of urinary urgency incontinence alone or in combination with urinary urgency and/or urinary frequency.

Urinary Urgency Incontinence – Males and Females

A Real World Study of eCoin® for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

  • A multi-center, prospective, single-arm study to assess the 5-year safety and effectiveness of the eCoin® device, an FDA-approved product that provides tibial neuromodulation therapy for the treatment of overactive bladder and urinary urge incontinence, in the post-approval setting.

Prostate Cancer – Males

Prospective, Multicenter, Single-Arm Study of Vanquish™ Water Vapor Ablation for PrOstate CanceR

  • A single-arm medical device trial to evaluate the safety and effectiveness of the Vanquish Water Vapor Ablation Device (“Vanquish”) in subjects with localized intermediate-risk prostate cancer.

Prostate Cancer – Males

A Multi-Center, Prospective, Observational Study of Patients Being Treated with ORGOVYX®

  • A data registry study to generate additional evidence about 1) the safety and effectiveness of the ORGOVYX drug being used by patients as part of their routine clinical care and 2) the clinical course of patients during ORGOVYX treatment and following cessation of ORGOVYX.

Prostate Cancer – Males

Genetic Susceptibility and Management of Chronic Disease

  • A multi-center lab study to identify differentially expressed genes associated with prostate cancer and other types of cancer.

Prostate Cancer – Males

A Prospective, Non-randomized, Single-Blind, Multi-site Study for Supplemental Clinical Validation of the IsoPSA Assay

  • A multi-center lab study to validate the clinical performance characteristics of the IsoPSA to aid in discriminating between 1) the risk of prostate cancer and benign prostate conditions and 2) the risk of high-grade vs low-grade prostate cancer.

 

 

Help Us Foster Innovation

Minnesota Urology welcomes participants in its clinical studies. Advancements in clinical care are made possible through patient volunteers who participate in clinical research. By participating in one of our studies, patients may have access to new and innovative treatments not otherwise available. Depending on the study, they also may be eligible to receive testing, treatment, and other clinical services at no cost, as well as study patient stipends and travel compensation. For more information or to determine if you may be eligible, call Clinical Research at 651-999-7032.

Skip to toolbar